IIM
BIO icon

InView Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

InView Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$971K Hold
8,260
– – 1.31% 42
2013
Q2 		$927K Buy
+8,260
New +$969K 1.39% 42

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

InView Investment Management's BIO Position: Q3 2013 in Review

InView Investment Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2013 at 8,260 shares worth $971K. The position accounts for 1.31% of the portfolio, ranked #42.

InView Investment Management first reported a position in BIO in Q2 2013 and has held it in 2 quarters since. 203 funds tracked by Wall St. Rank hold BIO as of Q3 2013.

  • InView Investment Management held 8,260 shares of Bio-Rad Laboratories Class A worth $971K as of Q3 2013.
  • InView Investment Management left its Bio-Rad Laboratories Class A share count unchanged in Q3 2013.
  • Bio-Rad Laboratories Class A made up 1.31% of InView Investment Management's portfolio in Q3 2013, its #42 holding.
  • InView Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 2 quarters since.
  • 203 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2013.

Based on InView Investment Management's 13F filing for Q3 2013, filed 29 Oct 2013.